{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:36:11Z","timestamp":1790472971617,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.molmed.2006.06.001","type":"journal-article","created":{"date-parts":[[2006,6,24]],"date-time":"2006-06-24T11:27:14Z","timestamp":1151148434000},"page":"367-373","source":"Crossref","is-referenced-by-count":77,"title":["Stop-codon read-through for patients affected by a lysosomal storage disorder"],"prefix":"10.1016","volume":"12","author":[{"given":"Doug A.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viv J.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Hopwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2006.06.001_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.molmed.2006.06.001_bib2","series-title":"The metabolic and molecular basis of inherited diseases","year":"2001"},{"key":"10.1016\/j.molmed.2006.06.001_bib3","series-title":"Lysosomal disorders of the brain","first-page":"32","article-title":"Lysosomal defects and storage","author":"Platt","year":"2004"},{"key":"10.1016\/j.molmed.2006.06.001_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00711309","article-title":"Immunochemical analysis of lysosomal enzymes in mucopolysaccharidosis type I and type VI patients","volume":"16","author":"Brooks","year":"1993","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.molmed.2006.06.001_bib5","series-title":"Lysosomal disorders of the brain","first-page":"50","article-title":"Clinical aspects and diagnosis","author":"Wraith","year":"2004"},{"key":"10.1016\/j.molmed.2006.06.001_bib6","first-page":"3074","article-title":"Histological improvement and enzyme replacement in the brains of fucosidosis dogs after bone marrow engraftment","volume":"21","author":"Taylor","year":"1989","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.molmed.2006.06.001_bib7","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/BF00711520","article-title":"Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype","volume":"16","author":"Hopwood","year":"1993","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.molmed.2006.06.001_bib8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1023\/A:1005525931994","article-title":"Long-term follow-up following bone marrow transplantation for Hunter disease","volume":"22","author":"Vellodi","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.molmed.2006.06.001_bib9","first-page":"273","article-title":"Pathology of the liver in mucopolysaccharidosis: light and electron microscopic assessment before and after bone marrow transplantation","volume":"10","author":"Resnick","year":"1992","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.molmed.2006.06.001_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","article-title":"Therapeutic goals in the treatment of Gaucher disease","volume":"41","author":"Pastores","year":"2004","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.molmed.2006.06.001_bib11","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.1542\/peds.2004-1023","article-title":"Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase","volume":"115","author":"Harmatz","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.molmed.2006.06.001_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00063030-200519010-00001","article-title":"Laronidase treatment of mucopolysaccharidosis I","volume":"19","author":"Wraith","year":"2005","journal-title":"BioDrugs"},{"key":"10.1016\/j.molmed.2006.06.001_bib13","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1242\/jcs.00075","article-title":"A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology","volume":"115","author":"Kuronita","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molmed.2006.06.001_bib14","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1017\/S1355838200000716","article-title":"Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system","volume":"6","author":"Manuvakhova","year":"2000","journal-title":"RNA"},{"key":"10.1016\/j.molmed.2006.06.001_bib15","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/nar\/21.13.3119","article-title":"The translational termination signal database","volume":"21","author":"Brown","year":"1993","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2006.06.001_bib16","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1073\/pnas.92.12.5431","article-title":"Translation termination efficiency in both bacteria and mammals is regulated by the base following the stop codon","volume":"92","author":"McCaughan","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2006.06.001_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jmb.2004.03.012","article-title":"\u03b1-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients","volume":"338","author":"Hein","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.molmed.2006.06.001_bib18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/humu.1380060403","article-title":"Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications","volume":"6","author":"Scott","year":"1995","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molmed.2006.06.001_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0925-4439(98)00046-5","article-title":"Genotype\u2013phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies","volume":"1407","author":"Bunge","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2006.06.001_bib20","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1093\/nar\/gki862","article-title":"Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding","volume":"33","author":"Francois","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2006.06.001_bib21","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1006\/jmbi.2000.4420","article-title":"Structural origins of aminoglycoside specificity for prokaryotic ribosomes","volume":"306","author":"Lynch","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.molmed.2006.06.001_bib22","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1164\/ajrccm.161.3.9904116","article-title":"A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations","volume":"161","author":"Wilschanski","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.molmed.2006.06.001_bib23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1531-8249(200008)48:2<164::AID-ANA5>3.0.CO;2-B","article-title":"Sequence specificity of aminoglycoside-induced stop codon read-through: potential implications for treatment of Duchenne muscular dystrophy","volume":"48","author":"Howard","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2006.06.001_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00109-002-0363-1","article-title":"Aminoglycoside suppression of a premature stop mutation in a CFTR\u2212\/\u2212 mouse carrying a human CFTR-G542X transgene","volume":"80","author":"Du","year":"2002","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.molmed.2006.06.001_bib25","doi-asserted-by":"crossref","first-page":"15676","DOI":"10.1073\/pnas.0405155101","article-title":"Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons","volume":"101","author":"Lai","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2006.06.001_bib26","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJMoa022170","article-title":"Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations","volume":"349","author":"Wilschanski","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2006.06.001_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/hmg\/10.3.291","article-title":"Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of \u03b1-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation","volume":"10","author":"Keeling","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2006.06.001_bib28","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/nar\/30.9.2011","article-title":"Predominance of six different hexanucleotide recoding signals 3\u2032 of read-through stop codons","volume":"30","author":"Harrell","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2006.06.001_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00109-006-0045-5","article-title":"Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model","volume":"84","author":"Du","year":"2006","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.molmed.2006.06.001_bib30","series-title":"Lysosomal disorders of the brain","first-page":"327","article-title":"Enzyme replacement therapy","author":"Neufeld","year":"2004"},{"key":"10.1016\/j.molmed.2006.06.001_bib31","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1474-4422(04)00938-X","article-title":"Enzyme-replacement therapy for metabolic storage disorders","volume":"3","author":"Brady","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molmed.2006.06.001_bib32","first-page":"359","article-title":"Stem cell bone marrow transplantation in patients with metabolic storage diseases","volume":"49","author":"Krivit","year":"2002","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.molmed.2006.06.001_bib33","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nrg963","article-title":"Enzyme replacement and enhancement therapies: lessons from lysosomal disorders","volume":"3","author":"Desnick","year":"2002","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2006.06.001_bib34","doi-asserted-by":"crossref","first-page":"43R","DOI":"10.1093\/glycob\/cwi076","article-title":"Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses","volume":"15","author":"Butters","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.molmed.2006.06.001_bib35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jgm.581","article-title":"Gene therapy for lysosomal storage diseases: the lessons and promise of animal models","volume":"6","author":"Ellinwood","year":"2004","journal-title":"J. Gene Med."},{"key":"10.1016\/j.molmed.2006.06.001_bib36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/humu.1189","article-title":"Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: diagnostic, clinical, and biological implications","volume":"18","author":"Yogalingam","year":"2001","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molmed.2006.06.001_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/sj.ejhg.5200242","article-title":"Sanfilippo type B syndrome (mucopolysaccharidosis IIIB): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes","volume":"7","author":"Weber","year":"1999","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2006.06.001_bib38","first-page":"950","article-title":"Mucopolysaccharidosis IVA: four new exonic mutations in patients with N-acetylgalactosamine-6-sulfate sulfatase deficiency","volume":"58","author":"Tomatsu","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2006.06.001_bib39","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/(SICI)1098-1004(1998)11:3<202::AID-HUMU4>3.0.CO;2-J","article-title":"Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and Northern Ireland: nine novel mutations including T312S, a common allele that confers a mild phenotype","volume":"11","author":"Yamada","year":"1998","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molmed.2006.06.001_bib40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/humu.1190","article-title":"Mucopolysaccharidosis type VI: structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase","volume":"18","author":"Litjens","year":"2001","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molmed.2006.06.001_bib41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1172\/JCI3112","article-title":"Molecular genetics of palmitoyl-protein thioesterase deficiency in the US","volume":"102","author":"Das","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2006.06.001_bib42","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1086\/514846","article-title":"Spectrum of mutations in the Batten disease gene, CLN3","volume":"61","author":"Munroe","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2006.06.001_bib43","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ajmg.1320490212","article-title":"Mutation analysis of 28 Gaucher disease patients: the Australasian experience","volume":"49","author":"Lewis","year":"1994","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.molmed.2006.06.001_bib44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1056\/NEJM199101033240104","article-title":"Molecular basis of different forms of metachromatic leukodystrophy","volume":"324","author":"Polten","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2006.06.001_bib45","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1242\/jcs.01701","article-title":"Nonsense-mediated mRNA decay in mammals","volume":"118","author":"Maquat","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molmed.2006.06.001_bib46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ceb.2005.04.005","article-title":"Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species","volume":"17","author":"Conti","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.molmed.2006.06.001_bib47","doi-asserted-by":"crossref","unstructured":"Kuzmiak, H.A. and Maquat, L.E. (2006) Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges. Trends Mol. Med. (in press)","DOI":"10.1016\/j.molmed.2006.05.005"},{"key":"10.1016\/j.molmed.2006.06.001_bib48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrm760","article-title":"Messenger-RNA-binding proteins and the messages they carry","volume":"3","author":"Dreyfuss","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2006.06.001_bib49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2443.1998.00191.x","article-title":"How protein reads the stop codon and terminates translation","volume":"3","author":"Nakamura","year":"1998","journal-title":"Genes Cells"},{"key":"10.1016\/j.molmed.2006.06.001_bib50","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1093\/nar\/29.23.4767","article-title":"Misreading of termination codons in eukaryotes by natural nonsense suppressor tRNAs","volume":"29","author":"Beier","year":"2001","journal-title":"Nucleic Acids Res."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491406001183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491406001183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T14:52:19Z","timestamp":1555685539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491406001183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S1471491406001183"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2006.06.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}